S. Natarajan

Statistics

Publications

Citations

903

H-Index

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Illinois Chicago

Scripps Research Institute

Leo Pharma (Denmark)

University College London

S. Natarajan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, natural sciences, and organic chemistry.

ORCID

Publications per year

1992–2015

Publications

Practical olefin hydroamination with nitroarenes

Jinghan Gui, Chung‐Mao Pan, Ying Jin et al. · Science · 2015 · 533 citations

Natural Sciences, Chemistry, Medicinal Chemistry +8

CH Oxidation of Ingenanes Enables Potent and Selective Protein Kinase C Isoform Activation

Yehua Jin, Chien‐Hung Yeh, Christian A. Kuttruff et al. · Angewandte Chemie International Edition · 2015 · 46 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +7

p38MAP kinase inhibitors. part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold

S. Natarajan, David D. Wisnoski, Suresh B. Singh et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Synthesis of the taxol AB-system by olefination of an A-ring C1 ketone and direct B-ring closure

David Crich, S. Natarajan, J. Z. CRICH · Tetrahedron · 1997 · 28 citations

Natural Sciences, Chemistry, Medicinal Chemistry +8

Rapid Access to Pyrazolo[3,4-<i>c</i>]pyridines via Alkyne Annulation: Limitations of Steric Control in Nickel-Catalyzed Alkyne Insertions

Stephen T. Heller, S. Natarajan · Organic Letters · 2007 · 28 citations

Natural Sciences, Chemistry, Catalysis +16

1–5 of 19